Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M.F. Uhrmann
Pms7 - Loss of Qalys Associated With Biosimilar Discontinuation Due to Nocebo Effect
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Php184 - Patient Influence on Biosimilar Uptake: The Nocebo Effect
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Alendronate Prevents Loss of Bone Density Associated With Discontinuation of Hormone Replacement Therapy
Archives of Internal Medicine
Erratum To: Medication Use Following Bariatric Surgery: Factors Associated With Early Discontinuation
Obesity Surgery
Nutrition
Endocrinology
Dietetics
Surgery
Metabolism
Diabetes
Infusion Reactions Related to Infliximab Therapy Are Not Usually Associated With Drug Discontinuation
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Estimate of Maximum Insurance Loss Due to Bushfires
Discontinuation of a Randomised Controlled Trial in General Practice Due to Unsuccessful Patient Recruitment
BJGP Open
The PROMIS of QALYs
Health and Quality of Life Outcomes
Medicine
Environmental
Public Health
Occupational Health
Quantifying Interpretability Loss Due to Image Compression
Letter: Is There a Role for Infliximab Biosimilar in Patients With Inflammatory Bowel Disease With Secondary Loss of Response to Infliximab Innovator?
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
